Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance P-hepatic stellate cells-hepatocellular carcinoma” axis
Autor: | Li, Zhipeng a, 1, Wang, Fangqing a, 1, Li, Yanying a, 1, Wang, Xiaoxue a, Lu, Qiao a, Wang, Di b, Qi, Cuiping b, Li, Chenglei c, Li, Zhaohuan c, Lian, Bo a, Tian, Guixiang a, Gao, Zhiqin a, ∗∗, Zhang, Bo c, ∗∗∗, Wu, Jingliang a, ∗ |
---|---|
Zdroj: | In Biomaterials September 2021 276 |
Databáze: | ScienceDirect |
Externí odkaz: |